We utilize innovative molecular and computational approaches to
- Explore the functional RNA binding activity of the nucleocytoplasmic transport (NCT) machinery disrupted in neurodegeneration.
- Map the RNA-protein interaction networks that drive breast cancer progression and plasticity.
- Evaluate RNA-based therapeutics in cell-line models, animal models, and patient tissues.